1. Auranofin is a potent suppressor of osteosarcoma metastasis
   Eleni Topkas et al, 2016, Oncotarget CrossRef
2. ROS-Mediated Therapeutic Strategy in Chemo-/Radiotherapy of Head and Neck Cancer
   Gan Huang et al, 2020, Oxidative Medicine and Cellular Longevity CrossRef
3. Why Nature Chose Selenium
   Hans J. Reich et al, 2016, ACS Chemical Biology CrossRef
4. TXNRD1 Is an Unfavorable Prognostic Factor for Patients with Hepatocellular Carcinoma
   Binsheng Fu et al, 2017, BioMed Research International CrossRef
5. The role of thioredoxin system in cancer: strategy for cancer therapy
   Jin-Jing Jia et al, 2019, Cancer Chemotherapy and Pharmacology CrossRef
6. Mitocans: Mitochondrially Targeted Anti-cancer Drugs
   Stepana Boukalova et al, 2018, Mitochondrial Biology and Experimental Therapeutics CrossRef
7. Inhibition of thioredoxin 1 leads to apoptosis in drug-resistant multiple myeloma
   Prahlad V. Raninga et al, 2015, Oncotarget CrossRef
8. Identification of Potential Biomarkers Using Integrative Approach: A Case Study of ESCC
   Manaswita Saikia et al, 2022, SN Computer Science CrossRef
9. Acetylated Thioredoxin Reductase 1 Resists Oxidative Inactivation
   David. E. Wright et al, 2021, Frontiers in Chemistry CrossRef
10. Anti-Cancer Effects of Auranofin in Human Lung Cancer Cells by Increasing Intracellular ROS Levels and Depleting GSH Levels
    Xia Ying Cui et al, 2022, Molecules CrossRef
11. Thioredoxin 1 is required for stress granule assembly upon arsenite-induced oxidative stress
    Bogdan Jovanovic et al, 2021, Food and Chemical Toxicology CrossRef
12. Auranofin radiosensitizes tumor cells through targeting thioredoxin reductase and resulting overproduction of reactive oxygen species
    Hui Wang et al, 2017, Oncotarget CrossRef